Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.



Tübingen, Germany


Post IPO Equity




Org chart

Carsten Reinhardt
Managing Director & Chief Development Officer
Rainer Kramer
Managing Director & Chief Business Officer
Toni Weinschenk
Chief Innovation Officer
Cedrik Britten
Chief Medical Officer
Arnd Christ
Chief Financial Officer
Steffen Walter
Chief Technology Officer
Edward Sturchio
General Counsel
Jessica Mosby
VP, Operations US & Site Head Houston
Dominik Maurer
VP, Immunology & Site Head Tuebingen
Jens Fritsche
VP, Bioinformatics
Claudia Blattner
Director, Business Development & Partnering
Wolfgang Flasche
Director, Intellectual Property
Miriam Meyer
Senior Director, EU Regulatory Affairs
Michael Mølhøj
Senior Director, CMC Biologics
Ami Miller
Director of Quality Control
Katharina Kiesel
Director of Project Management
Olga Veremchuk
Director of Clinical Development
Dmitry Pankov
Director, Clinical Development
Fabian Richter
Director, TCR Discovery
Anja Heuer
Corporate Communications Manager
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.